PLASMIC score for estimating the risk of ADAMPTS13 deficiency: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{CMG}}; {{AE}} {{Saeedeh}} ==Overview== ==PLASMIC score == {{#Widget:PLASMIC score}} </br> '''Risk of ADAMPTS13 deficiency:''' '''Low-risk''' = 0 to 4 points '''Intermediat...")
 
 
(6 intermediate revisions by the same user not shown)
Line 3: Line 3:
==PLASMIC score ==
==PLASMIC score ==
{{#Widget:PLASMIC score}}
{{#Widget:PLASMIC score}}
</br>
<br>
'''Risk of ADAMPTS13 deficiency:'''
'''<big>Risk of ADAMPTS13 deficiency</big>'''  '''<big>in adults with suspected TTP</big>''' <ref name="JammeRondeau2017">{{cite journal|last1=Jamme|first1=Matthieu|last2=Rondeau|first2=Eric|title=The PLASMIC score for thrombotic thrombocytopenic purpura|journal=The Lancet Haematology|volume=4|issue=4|year=2017|pages=e148–e149|issn=23523026|doi=10.1016/S2352-3026(17)30024-8}}</ref>'''<big>:</big>'''
'''Low-risk''' = 0 to 4 points  
* '''Low-risk''' = 0 to 4 points  
 
* '''Intermediate risk''' = 5 points
'''Intermediate risk''' = 5 points
* '''High-risk''' = 6 to 7 points
 
==References==
'''High-risk''' = 6 to 7 points
<references />

Latest revision as of 15:57, 23 August 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]

Overview

PLASMIC score

Platelet count (< 30,000/microL)
Hemolysis variables (Retic count > 2.5%, undetectable haptoglobin, indirect billi <2 mg/dL( >34 mcmol/L))
Absence of active cancer
Absence of transplant history (solid, stem cell)
MCV < 90 Fl
INR < 1.5
Serum creatinine < 2 mg/dL (<177 mcmol/L)
Score:

Risk of ADAMPTS13 deficiency in adults with suspected TTP [1]:

  • Low-risk = 0 to 4 points
  • Intermediate risk = 5 points
  • High-risk = 6 to 7 points

References

  1. Jamme, Matthieu; Rondeau, Eric (2017). "The PLASMIC score for thrombotic thrombocytopenic purpura". The Lancet Haematology. 4 (4): e148–e149. doi:10.1016/S2352-3026(17)30024-8. ISSN 2352-3026.